|
ACAT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32986979603811E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.01359999948869E-07 |
| Normal-vs-Stage3 |
5.79040038140022E-10 |
| Normal-vs-Stage4 |
8.511800E-02 |
| Stage1-vs-Stage2 |
3.621800E-01 |
| Stage1-vs-Stage3 |
7.426400E-01 |
| Stage1-vs-Stage4 |
1.274960E-01 |
| Stage2-vs-Stage3 |
6.159000E-01 |
| Stage2-vs-Stage4 |
2.269000E-01 |
| Stage3-vs-Stage4 |
9.195600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626032641866E-12 |
| Normal-vs-AfricanAmerican |
8.65973959207622E-15 |
| Normal-vs-Asian |
2.06499999999554E-06 |
| Caucasian-vs-AfricanAmerican |
8.693200E-01 |
| Caucasian-vs-Asian |
6.855800E-01 |
| AfricanAmerican-vs-Asian |
5.764800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62558855265615E-12 |
| Normal-vs-Female |
3.70514730008153E-12 |
| Male-vs-Female |
1.582410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66555658154266E-12 |
| Normal-vs-Extreme_Weight |
1.62492241884138E-12 |
| Normal-vs-Obese |
1.18269838367269E-11 |
| Normal-vs-Extreme_Obese |
6.76660000253904E-08 |
| Normal_Weight-vs-Extreme_Weight |
6.563400E-01 |
| Normal_Weight-vs-Obese |
2.488000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.684600E-01 |
| Extreme_Weight-vs-Obese |
7.747800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.315000E-01 |
| Obese-vs-Extreme_Obese |
4.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04539998879716E-09 |
| Normal-vs-Age(41-60Yrs) |
1.63125069008174E-12 |
| Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(81-100Yrs) |
2.028099910234E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.092800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.647800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.236200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.171800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.437000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.61519997377013E-09 |
| Normal-VS-KIRP CIMP |
1.828050E-02 |
| Normal-VS-Unclassified PRCC |
7.80389974863738E-10 |
| Type1 PRCC-VS-Type2 PRCC |
8.957000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.035800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.257600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.192200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.302800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.356600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36712904622527E-13 |
| Normal-vs-N1 |
5.627200E-04 |
| Normal-vs-N2 |
9.0991000289975E-09 |
| N0-vs-N1 |
5.586300E-02 |
| N0-vs-N2 |
5.632200E-02 |
| N1-vs-N2 |
3.672300E-02 |
|
|
